Epidemiology of glioblastoma;Épidémiologie des glioblastomes

Neurochirurgie

Volumn 56, Issue 6, 2010, Pages 433-440

  Baldi, I ^a   Huchet, A ^a   Bauchet, L ^b   Loiseau, H ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Brain tumor; Epidemiology; Glioblastoma; Incidence; Registry; Risk factor

Indexed keywords

ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; PESTICIDE; SOLVENT;

AGE; AGING; ALLERGY; ASTHMA; AUTOIMMUNE DISEASE; BRAIN RADIATION; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIETARY INTAKE; DRUG UPTAKE; ELECTROMAGNETIC FIELD; ENVIRONMENTAL EXPOSURE; ETHNICITY; FRANCE; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; GLIOBLASTOMA; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MOBILE PHONE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; REVIEW; RISK FACTOR; SEX; VIRUS INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CHILD; FEMALE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOBLASTOMA; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 79953332199     PISSN: 00283770     EISSN: 17730619     Source Type: Journal    
DOI: 10.1016/j.neuchi.2010.07.011     Document Type: Review

References (89)

1. Aldape K., Simmons M.L., Davis R.L., Miike R., Wiencke J., et al. Discrepancies in diagnosis of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study. Cancer 2000, 88:2342-2349.
2. Aldrich T.E., Andrews K.W., Liboff A.R. Brain cancer risk and electromagnetic fields (EMFs): assessing the geomagnetic component. Arch. Environ. Health 2001, 56:314-319.
3. Balasubramaniam A., Shannon P., Hodaie M., Laperriere N., Michaels H., et al. Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro. Oncol. 2007, 9:447-453.
4. Bauchet L., Rigau V., Mathieu-Daude H., Figarella-Branger D., Hugues D., et al. French brain tumor data bank: methodology and first results on 10,000 cases. J. Neurooncol. 2007, 84:189-199.
5. Bethke L., Murray A., Webb E., Schoemaker M., Muir K., et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J. Natl. Cancer Inst. 2008, 100:270-276.
6. Blettner M., Schlehofer B., Samkange-Zeeb F., Berg G., Schlaefer K., et al. Medical exposure to ionising radiation and the risk of brain tumours: Interphone study group, Germany. Eur. J. Cancer 2007, 43:1990-1998.
7. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113:1953-1968.
8. Brenner A.V., Butler M.A., Wang S.S., Ruder A.M., Rothman N., et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007, 28:2543-2547.
9. Brenner A.V., Linet M.S., Shapiro W.R., Selker R.G., Fine H.A., et al. Season of birth and risk of brain tumors in adults. Neurology 2004, 63:276-281.
10. Brenner D.J., Doll R., Goodhead D.T., Hall E.J., Land C.E., et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl. Acad. Sci. USA. 2003, 100:13761-13766.
11. Brown M., Schrot R., Bauer K., Letendre D. Incidence of first primary central nervous system tumors in California, 2001-2005. J. Neurooncol. 2009, 94:249-261.
12. Christensen H.C., Kosteljanetz M., Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 2003, 52:1327-1333. (discussion 1333-4).
13. Counsell C.E., Collie D.A., Grant R. Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90. J. Neurol. Neurosurg. Psychiatry 1996, 61:143-150.
14. Darefsky A.S., Dubrow R. International variation in the incidence of adult primary malignant neoplasms of the brain and central nervous system. Cancer Causes Control 2009, 20:1593-1604.
15. Davis F.G., Freels S., Grutsch J., Barlas S., Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J. Neurosurg. 1998, 88:1-10.
16. Dearlove J.V., Fisher P.G., Buffler P.A. Family history of cancer among children with brain tumors: a critical review. J. Pediatr. Hematol. Oncol. 2008, 30:8-14.
17. Deltour I., Johansen C., Auvinen A., Feychting M., Klaeboe L., et al. Time Trends in Brain Tumor Incidence Rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J. Natl. Cancer Inst. 2009.
18. Deorah S., Lynch C.F., Sibenaller Z.A., Ryken T.C. Trends in brain cancer incidence and survival in the United States: surveillance epidemiology, and end results program, 1973 to 2001. Neurosurg. Focus 2006, 20:E1.
19. Dreifaldt A.C., Carlberg M., Hardell L. Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. Eur. J. Cancer 2004, 40:1351-1360.
20. Efird J.T., Friedman G.D., Sidney S., Klatsky A., Habel L.A., et al. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J. Neurooncol. 2004, 68:57-69.
21. Elia-Pasquet S., Provost D., Jaffre A., Loiseau H., Vital A., et al. Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology 2004, 23:110-117.
22. Elwood J.M. Epidemiological studies of radio frequency exposures and human cancer. Bioelectromagnetics 2003, (Suppl. 6):S63-S73.
23. Erfurth E.M., Bulow B., Mikoczy Z., Hagmar L. Incidence of a second tumor in hypopituitary patients operated for pituitary tumors. J. Clin. Endocrinol. Metab. 2001, 86:659-662.
24. Evans D.G., Birch J.M., Ramsden R.T., Sharif S., Baser M.E. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J. Med. Genet. 2006, 43:289-294.
25. Fleury A., Menegoz F., Grosclaude P., Daures J.P., Henry-Amar M., et al. Descriptive epidemiology of cerebral gliomas in France. Cancer 1997, 79:1195-1202.
26. Gousias K., Markou M., Voulgaris S., Goussia A., Voulgari P., et al. Descriptive epidemiology of cerebral gliomas in northwest Greece and study of potential predisposing factors, 2005-2007. Neuroepidemiology 2009, 33:89-95.
27. Greig N.H., Ries L.G., Yancik R., Rapoport S.I. Increasing annual incidence of primary malignant brain tumors in the elderly. J. Natl. Cancer Inst. 1990, 82:1621-1624.
28. Grossman S.A., Osman M., Hruban R., Piantadosi S. Central nervous system cancers in first-degree relatives and spouses. Cancer Invest. 1999, 17:299-308.
29. Hardell L., Carlberg M., Soderqvist F., Hansson Mild K. Meta-analysis of long-term mobile phone use and the association with brain tumours. Int. J. Oncol. 2008, 32:1097-1103.
30. Hardell L., Nasman A., Pahlson A., Hallquist A., Hansson Mild K. Use of cellular telephones and the risk for brain tumours: a case-control study. Int. J. Oncol. 1999, 15:113-116.
31. Hatch E.E., Linet M.S., Zhang J., Fine H.A., Shapiro W.R., et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int. J. Cancer 2005, 114:797-805.
32. Helseth A. The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J. Neurosurg. 1995, 83:999-1003.
33. Hemminki K., Li X. Familial risks in nervous system tumors. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1137-1142.
34. Hess K.R., Broglio K.R., Bondy M.L. Adult glioma incidence trends in the United States, 1977-2000. Cancer 2004, 101:2293-2299.
35. Heuch J.M., Heuch I., Akslen L.A., Kvale G. Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. Int. J. Cancer 1998, 77:498-503.
36. Hoffman S., Propp J.M., McCarthy B.J. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro. Oncol. 2006, 8:27-37.
37. Hogervorst J.G., Schouten L.J., Konings E.J., Goldbohm R.A., van den Brandt P.A. Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol. Biomarkers Prev. 2009, 18:1663-1666.
38. Huang K., Whelan E.A., Ruder A.M., Ward E.M., Deddens J.A., et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol. Biomarkers Prev. 2004, 13:1583-1588.
39. Huncharek M., Kupelnick B. A meta-analysis of maternal cured meat consumption during pregnancy and the risk of childhood brain tumors. Neuroepidemiology 2004, 23:78-84.
40. Johannesen T.B., Angell-Andersen E., Tretli S., Langmark F., Lote K. Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology 2004, 23:101-109.
41. Jukich P.J., McCarthy B.J., Surawicz T.S., Freels S., Davis F.G. Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro. Oncol. 2001, 3:141-151.
42. Kan P., Simonsen S.E., Lyon J.L., Kestle J.R. Cellular phone use and brain tumor: a meta-analysis. J. Neurooncol. 2008, 86:71-78.
43. Kaneko S., Nomura K., Yoshimura T., Yamaguchi N. Trend of brain tumor incidence by histological subtypes in Japan: estimation from the Brain Tumor Registry of Japan, 1973-1993. J. Neurooncol. 2002, 60:61-69.
44. Karipidis K.K., Benke G., Sim M.R., Yost M., Giles G. Occupational exposure to low frequency magnetic fields and the risk of low grade and high grade glioma. Cancer Causes Control 2007, 18:305-313.
45. Khuder S.A., Mutgi A.B., Schaub E.A. Meta-analysis of brain cancer and farming. Am. J. Ind. Med. 1998, 34:252-260.
46. Kundi M. The controversy about a possible relationship between mobile phone use and cancer. Environ. Health Perspect. 2009, 117:316-324.
47. Kundi M., Mild K., Hardell L., Mattsson M.O. Mobile telephones and cancer-a review of epidemiological evidence. J. Toxicol. Environ. Health B Crit. Rev. 2004, 7:351-384.
48. Kuratsu J., Takeshima H., Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto. Japan. Int. J. Clin. Oncol. 2001, 6:183-191.
49. Kuratsu J., Ushio Y. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J. Neurosurg. 1996, 84:946-950.
50. Lahkola A., Auvinen A., Raitanen J., Schoemaker M.J., Christensen H.C., et al. Mobile phone use and risk of glioma in 5 North European countries. Int. J. Cancer 2007, 120:1769-1775.
51. Larjavaara S., Mantyla R., Salminen T., Haapasalo H., Raitanen J., et al. Incidence of gliomas by anatomic location. Neuro. Oncol. 2007, 9:319-325.
52. Legler J.M., Ries L.A., Smith M.A., Warren J.L., Heineman E.F., et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J. Natl. Cancer Inst. 1999, 91:1382-1390.
53. Liigant A., Asser T., Kulla A., Kaasik A.E. Epidemiology of primary central nervous system tumors in Estonia. Neuroepidemiology 2000, 19:300-311.
54. Linos E., Raine T., Alonso A., Michaud D. Atopy and risk of brain tumors: a meta-analysis. J. Natl. Cancer Inst. 2007, 99:1544-1550.
55. Loiseau H., Huchet A., Rue M., Cowppli-Bony A., Baldi I. [Epidemiology of primary brain tumor]. Rev. Neurol. (Paris) 2009, 165:650-670.
56. Lonn S., Klaeboe L., Hall P., Mathiesen T., Auvinen A., et al. Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int. J. Cancer. 2004, 108:450-455.
57. Louis D.N., Ohgaki H., Wiestler O.D., Cavennee W.C. WHO classification of tumours of the central nervous system 2007, International agency for research on cancer, Lyon.
58. Lubin F., Farbstein H., Chetrit A., Farbstein M., Freedman L., et al. The role of nutritional habits during gestation and child life in pediatric brain tumor etiology. Int. J. Cancer 2000, 86:139-143.
59. Malmer B., Adatto P., Armstrong G., Barnholtz-Sloan J., Bernstein J.L., et al. GLIOGENE an international consortium to understand familial glioma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1730-1734.
60. Malmer B., Gronberg H., Bergenheim A.T., Lenner P., Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999, 81:366-370.
61. Malmer B., Henriksson R., Gronberg H. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int. J. Cancer 2003, 106:260-263.
62. Mandelzweig L., Novikov I., Sadetzki S. Smoking and risk of glioma: a meta-analysis. Cancer Causes Control 2009, 20:1927-1938.
63. McKinley B.P., Michalek A.M., Fenstermaker R.A., Plunkett R.J. The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995. J. Neurosurg. 2000, 93:932-939.
64. Minniti G., Traish D., Ashley S., Gonsalves A., Brada M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J. Clin. Endocrinol. Metab. 2005, 90:800-804.
65. Neglia J.P., Robison L.L., Stovall M., Liu Y., Packer R.J., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Natl. Cancer Inst. 2006, 98:1528-1537.
66. Provost D., Cantagrel A., Lebailly P., Jaffre A., Loyant V., et al. Brain tumours and exposure to pesticides: a case-control study in southwestern France. Occup. Environ. Med. 2007, 64:509-514.
67. Radhakrishnan K., Mokri B., Parisi J.E., O'Fallon W.M., Sunku J., et al. The trends in incidence of primary brain tumors in the population of Rochester. Minnesota. Ann. Neurol. 1995, 37:67-73.
68. Ron E., Modan B., Boice J.D., Alfandary E., Stovall M., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N. Engl. J. Med. 1988, 319:1033-1039.
69. Ruder A.M., Carreon T., Butler M.A., Calvert G.M., Davis-King K.E., et al. Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study. Am. J. Epidemiol. 2009, 169:1479-1491.
70. Sadetzki S., Zach L., Chetrit A., Nass D., Hoffmann C., et al. Epidemiology of gliomas in Israel: a nationwide study. Neuroepidemiology 2008, 31:264-269.
71. Samanic C.M., De Roos A.J., Stewart P.A., Rajaraman P., Waters M.A., et al. Occupational exposure to pesticides and risk of adult brain tumors. Am. J. Epidemiol. 2008, 167:976-985.
72. Scheurer M.E., El-Zein R., Thompson P.A., Aldape K.D., Levin V.A., et al. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:1277-1281.
73. Scheurer M.E., Etzel C.J., Liu M., El-Zein R., Airewele G.E., et al. Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2491-2495.
74. Schlehofer B., Blettner M., Preston-Martin S., Niehoff D., Wahrendorf J., et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int. J. Cancer 1999, 82:155-160.
75. Schlehofer B., Hettinger I., Ryan P., Blettner M., Preston-Martin S., et al. Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int. J. Cancer 2005, 113:116-125.
76. Schwartzbaum J., Jonsson F., Ahlbom A., Preston-Martin S., Lonn S., et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int. J. Cancer 2003, 106:423-428.
77. Schwartzbaum J.A., Ahlbom A., Lonn S., Malmer B., Wigertz A., et al. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol. Biomarkers Prev. 2007, 16:2448-2454.
78. Shah K.V. SV40 and human cancer: a review of recent data. Int. J. Cancer 2007, 120:215-223.
79. Shete S., Hosking F.J., Robertson L.B., Dobbins S.E., Sanson M., et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 2009, 41:899-904.
80. Shim Y.K., Mlynarek S.P., van Wijngaarden E. Parental exposure to pesticides and childhood brain cancer: U.S. Atlantic coast childhood brain cancer study. Environ. Health Perspect. 2009, 117:1002-1006.
81. Surawicz T.S., McCarthy B.J., Kupelian V., Jukich P.J., Bruner J.M., et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro. Oncol. 1999, 1:14-25.
82. Tedeschi-Blok N., Lee M., Sison J.D., Miike R., Wrensch M. Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study. BMC Cancer 2006, 6:148.
83. van Wijngaarden E., Dosemeci M. Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int. J. Cancer 2006, 119:1136-1144.
84. Villeneuve P.J., Agnew D.A., Johnson K.C., Mao Y. Brain cancer and occupational exposure to magnetic fields among men: results from a Canadian population-based case-control study. Int. J. Epidemiol. 2002, 31:210-217.
85. Wohrer A., Waldhor T., Heinzl H., Hackl M., Feichtinger J., et al. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J. Neurooncol. 2009, 95:401-411.
86. Wrensch M., Jenkins R.B., Chang J.S., Yeh R.F., Xiao Y., et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 2009, 41:905-908.
87. Wrensch M., Lee M., Miike R., Newman B., Barger G., et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am. J. Epidemiol. 1997, 145:581-593.
88. Wrensch M., Minn Y., Chew T., Bondy M., Berger M.S. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro. Oncol. 2002, 4:278-299.
89. Wrensch M., Weinberg A., Wiencke J., Miike R., Sison J., et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am. J. Epidemiol. 2005, 161:929-938.